Work

First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH

Year: 2019

Type: article

Study design: Observational Study

Source: Cancer Causes & Control

DOI: 10.1007/s10552-019-1133-5

Authors: Kagan Griffin, Ilona Csizmadi, Lauren E. Howard, Gina-Maria Pomann, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Martha K. Terris, Jennifer Beebe-Dimmer, Stephen J. Freedland

Institutions: Veterans Health Administration, Durham VA Medical Center, Cedars-Sinai Medical Center, Duke University, Duke Medical Center, University of California, Los Angeles, Los Angeles Medical Center, University of California San Diego, University of California San Diego Medical Center, Oregon Health & Science University, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Augusta University, Charlie Norwood VA Medical Center, Wayne State University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1324972186, G5468892234, Role of GPR120 and Macrophages in Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer, UCLA SPORE in Prostate Cancer, G864096937, G9000192302

OpenAlex ID: W2911627432

FWCI: 0.368

Cites: 34

Cited by: 6

Related to: 10